Resumes
Resumes
Owner
View pageLocation:
9532 Roseapple Dr, Indianapolis, IN 46256
Industry:
Pharmaceuticals
Work:
Amada Senior Care of Greater Indianapolis
Owner
Eli Lilly and Company
Lean Six Sigma Black Belt
Eli Lilly and Company 2013 - 2015
Chief Operations Officer and Director of Business Operations, Medical Affairs
Eli Lilly and Company 2013 - 2015
Chief Operating Officer - Lilly Diabetes Global Medical Affairs
Eli Lilly and Company Jun 2011 - Jul 2012
Lilly Diabetes Global Operations Advisor at Eli Lilly and Company
Owner
Eli Lilly and Company
Lean Six Sigma Black Belt
Eli Lilly and Company 2013 - 2015
Chief Operations Officer and Director of Business Operations, Medical Affairs
Eli Lilly and Company 2013 - 2015
Chief Operating Officer - Lilly Diabetes Global Medical Affairs
Eli Lilly and Company Jun 2011 - Jul 2012
Lilly Diabetes Global Operations Advisor at Eli Lilly and Company
Education:
Indiana University Bloomington 2007 - 2009
Indiana University Bloomington 2002 - 2006
Indiana University Bloomington 2006 - 2006
North Dakota State University
Indiana University Bloomington 2002 - 2006
Indiana University Bloomington 2006 - 2006
North Dakota State University
Skills:
Clinical Trials
Pharmaceutical Industry
Drug Development
Clinical Research
Regulatory Submissions
Regulatory Affairs
Fda
Diabetes
Business Planning
Business Process Improvement
Resource Management
Development of Employees
Small Business
Negotiation
Organization
Strategic Planning
Project Management
Strategic Partnerships
Technology Transfer
Oncology
Ctms
Clinical Development
Therapeutic Areas
Gcp
Sop
Drug Discovery
Cro
Biopharmaceuticals
21 Cfr Part 11
Validation
Gmp
U.s. Food and Drug Administration
Pharmaceutical Industry
Drug Development
Clinical Research
Regulatory Submissions
Regulatory Affairs
Fda
Diabetes
Business Planning
Business Process Improvement
Resource Management
Development of Employees
Small Business
Negotiation
Organization
Strategic Planning
Project Management
Strategic Partnerships
Technology Transfer
Oncology
Ctms
Clinical Development
Therapeutic Areas
Gcp
Sop
Drug Discovery
Cro
Biopharmaceuticals
21 Cfr Part 11
Validation
Gmp
U.s. Food and Drug Administration